Insights: News Kilpatrick Townsend Attorneys Earn Notable Acknowledgement as 2022 IAM Global Leaders
Kilpatrick Townsend Attorneys Earn Notable Acknowledgement as 2022 IAM Global Leaders
ATLANTA (July 27) – Kilpatrick Townsend & Stockton announced that seven of the firm’s attorneys were selected for recognition on the 2022 IAM Global Leaders list.
Following an extensive research process, thousands of written submissions, face-to-face and phone interviews and intense correspondence, only attorneys ranked in the gold tier of the IAM Patent 1000 who merit outstanding mention are named to the IAM Global Leaders list. These attorneys display incredible patent law expertise and exhibit special abilities to innovate and inspire.
To read more about IAM Global Leaders, please click here.
The following Kilpatrick Townsend attorneys were recognized on the 2022 IAM Global Leaders list:
Thomas Franklin is a partner in the firm’s Denver office. He focuses his practice on patent prosecution, licensing and intellectual capital management with more than 20 years of experience in intellectual property audits, due diligence and strategic planning processes.
Darin Gibby is a partner in the firm’s Denver office. With over 25 years of experience, he focuses his practice on intellectual property counseling, transactions, and licensing matters as well as patent prosecution.
David Sipiora is a retired partner at the firm’s Denver office. David was Co-Chair of Patent Litigation and oversaw a team of over 80 lawyers. His practice spanned across all intellectual property matter areas with special focus on patent litigation and licensing, trademark prosecution and counseling, and trade secret litigation and counseling.
Wab Kadaba is a partner and Chair of the firm’s Intellectual Property Department. He concentrates his practice on litigation related to intellectual property as well as strategy and management of intellectual property and technology issues.
Mitch Stockwell is a partner at the firm’s Atlanta office. He focuses his practice on intellectual property dispute resolution, with particular emphasis on patent infringement, trade secret and related intellectual property litigation and licensing transactions.
Andrew Serafini is a partner at the firm’s Seattle office. His practice specializes in strategic and comprehensive intellectual property counseling and management for biotechnology, biopharmaceutical, and other life sciences clients.
Roger Wylie is Kilpatrick Townsend’s Managing Partner. He focuses his practice on patent prosecution and counseling, and advises start-up and established corporations, venture investors and other intellectual property stakeholders regarding all aspects of patent prosecution and acquisition, counseling, licensing and litigation.
Intellectual Asset Management (IAM) was launched in July 2003 to address the need for organizations to maximize the value of their IP and other intangibles, and to examine the strategies they can put in place to do this. IAM is unique because it treats IP as a business asset and tool rather than simply as a legal right. Learn more about IAM, here.
Related People View All
While we are pleased to have you contact us by telephone, surface mail, electronic mail, or by facsimile transmission, contacting Kilpatrick Townsend & Stockton LLP or any of its attorneys does not create an attorney-client relationship. The formation of an attorney-client relationship requires consideration of multiple factors, including possible conflicts of interest. An attorney-client relationship is formed only when both you and the Firm have agreed to proceed with a defined engagement.
DO NOT CONVEY TO US ANY INFORMATION YOU REGARD AS CONFIDENTIAL UNTIL A FORMAL CLIENT-ATTORNEY RELATIONSHIP HAS BEEN ESTABLISHED.
If you do convey information, you recognize that we may review and disclose the information, and you agree that even if you regard the information as highly confidential and even if it is transmitted in a good faith effort to retain us, such a review does not preclude us from representing another client directly adverse to you, even in a matter where that information could be used against you.